The Journal of Clinical Endocrinology & Metabolism · 2004 · 460 citations · 27 references
Life SciencesPharmacologyPharmacotherapyEndocrine PharmacotherapyEnzymologySteroid BiochemistryAndrogen TherapyBenign Prostatic HyperplasiaSteroid Hormone BiochemistrySteroid Pharmacology5 Alpha-reductase5-Alpha-reductase Inhibition5-Alpha-reductase Inhibitor TherapyDaily DosingDutasteride TherapyFinasteride TherapyOnce-daily Dosing RegimensTestosterone Therapy
Dihydrotestosterone (DHT) is the primary metabolite of testosterone in the prostate and skin. Testosterone is converted to DHT by 5alpha-reductase, which exists in two isoenzyme forms (types 1 and 2). DHT is associated with development of benign prostatic hyperplasia (BPH), and reduction in its level with 5alpha-reductase inhibitors improves the symptoms associated with BPH and reduces the risk of acute urinary retention and prostate surgery. A selective inhibitor of the type 2 isoenzyme (finasteride) has been shown to decrease serum DHT by about 70%. We hypothesized that inhibition of both isoenzymes with the dual inhibitor dutasteride would more effectively suppress serum DHT levels than selective inhibition of only the type 2 isoenzyme. A total of 399 patients with BPH were randomized to receive once-daily dosing for 24 wk of dutasteride (0.01, 0.05, 0.5, 2.5, or 5.0 mg), 5 mg finasteride, or placebo. The mean percent decrease in DHT was 98.4 +/- 1.2% with 5.0 mg dutasteride and 94.7 +/- 3.3% with 0.5 mg dutasteride, significantly lower (P < 0.001) and with less variability than the 70.8 +/- 18.3% suppression observed with 5 mg finasteride. Mean testosterone levels increased but remained in the normal range for all treatment groups. Dutasteride appeared to be well tolerated with an adverse event profile similar to placebo.
27
Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism
Julianne Imperato‐McGinley, Luis Guerrero, Teófilo Gautier et al. · Science · 1974 · 1.3K citations
John D. McConnell, Reginald C. Bruskewitz, Patrick Walsh et al. · New England Journal of Medicine · 1998 · 1.1K citations · Full text